Track the 派林生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 派林生物 has published 23 reports. Market capitalisation: €10.1bn. The latest transaction was disclosed on 20 May 2026 (Purchase). Among the most active insiders: 黄灵谋. The full history is accessible without an account.
23
Insider Decl.
n/a
Thresholds
€545,445
17 ops.
Buy Volume
€16m
6 ops.
Sell Volume
22Σ signal
Buys €545,445€16m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,066 of 29,063 companies
49.1
score / 100
Value
38
Quality
60
FCF yld-5.6%
Earn yld4.2%
EV/EBITDA16.2x
ROE3.4%
Gross mgn42%
Net mgn16%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
